Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × NETWORK × Neuroblastoma × Clear all

Phase

Status

Completed 43 Active not recruiting 4 Withdrawn 2 Recruiting 2 Unknown 1 Terminated 1 No longer available 1

Sponsor Class

OTHER 34 INDUSTRY 13 NIH 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 19 Carcinoma, Non-Small-Cell Lung 18 Lymphoma 16 Breast Neoplasms 16 Neoplasm Metastasis 14 Lung Neoplasms 14 Carcinoma, Ovarian Epithelial 14 Colorectal Neoplasms 13 Sarcoma 12 Urinary Bladder Neoplasms 9 Prostatic Neoplasms 9 Head and Neck Neoplasms 9 Colonic Neoplasms 9 Central Nervous System Neoplasms 9 Astrocytoma 9 Squamous Cell Carcinoma of Head and Neck 8 Rectal Neoplasms 8 Mycosis Fungoides 8 Multiple Myeloma 8 Adenocarcinoma of Lung 8 Uterine Cervical Neoplasms 7 Recurrence 7 Oligodendroglioma 7 Melanoma 7 Sezary Syndrome 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Medulloblastoma 6 Lymphoma, T-Cell, Cutaneous 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Lymphocytic, Chronic, B-Cell 6

Interventions

Vincristine 1 Ketoconazole 1 Fenretinide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02163356 2022-03-31

SPOC2013-001

South Plains Oncology Consortium

Phase 1 Terminated

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡